Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim S Beyer

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
American Journal of Medical Genetics|February 13, 2002
Association studies of the HOPA dodecamer duplication variant in different subtypes of autismKim S Beyer, Sabine M Klauck, Axel Benner, et al.
Biochemical and Biophysical Research Communications|August 11, 2006
Magicin associates with the Src-family kinases and is phosphorylated upon CD3 stimulationMing-Fen Lee, Roberta L Beauchamp, Kim S Beyer, et al.
American Journal of Human Genetics|March 9, 2002
A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndromeSabine M Klauck, Susan Lindsay, Kim S Beyer, et al.
Human Genetics|October 18, 2002
Mutation analysis of the coding sequence of the MECP2 gene in infantile autismKim S Beyer, Francesca Blasi, Elena Bacchelli, et al.
The Journal of Biological Chemistry|September 13, 2007
Mediator subunit MED28 (Magicin) is a repressor of smooth muscle cell differentiationKim S Beyer, Roberta L Beauchamp, Ming-Fen Lee, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Optimization of a Fragment-Based Screening Hit toward Potent DOT1L Inhibitors Interacting in an Induced Binding PocketClemens Scheufler, Henrik Möbitz, Christoph Gaul, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
New Potent DOT1L Inhibitors for <i>in Vivo</i> Evaluation in MouseFrédéric Stauffer, Andreas Weiss, Clemens Scheufler, et al.
American Journal of Medical Genetics. Part A|April 15, 2009
FARP2, HDLBP and PASK are downregulated in a patient with autism and 2q37.3 deletion syndromeBärbel Felder, Bernhard Radlwimmer, Axel Benner, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking ApproachHenrik Möbitz, Rainer Machauer, Philipp Holzer, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation ApproachChao Chen, Hugh Zhu, Frédéric Stauffer, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
American Journal of Medical Genetics|February 13, 2002
Association studies of the HOPA dodecamer duplication variant in different subtypes of autismKim S Beyer, Sabine M Klauck, Axel Benner, et al.
Biochemical and Biophysical Research Communications|August 11, 2006
Magicin associates with the Src-family kinases and is phosphorylated upon CD3 stimulationMing-Fen Lee, Roberta L Beauchamp, Kim S Beyer, et al.
American Journal of Human Genetics|March 9, 2002
A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndromeSabine M Klauck, Susan Lindsay, Kim S Beyer, et al.
Human Genetics|October 18, 2002
Mutation analysis of the coding sequence of the MECP2 gene in infantile autismKim S Beyer, Francesca Blasi, Elena Bacchelli, et al.
The Journal of Biological Chemistry|September 13, 2007
Mediator subunit MED28 (Magicin) is a repressor of smooth muscle cell differentiationKim S Beyer, Roberta L Beauchamp, Ming-Fen Lee, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Optimization of a Fragment-Based Screening Hit toward Potent DOT1L Inhibitors Interacting in an Induced Binding PocketClemens Scheufler, Henrik Möbitz, Christoph Gaul, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
New Potent DOT1L Inhibitors for <i>in Vivo</i> Evaluation in MouseFrédéric Stauffer, Andreas Weiss, Clemens Scheufler, et al.
American Journal of Medical Genetics. Part A|April 15, 2009
FARP2, HDLBP and PASK are downregulated in a patient with autism and 2q37.3 deletion syndromeBärbel Felder, Bernhard Radlwimmer, Axel Benner, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking ApproachHenrik Möbitz, Rainer Machauer, Philipp Holzer, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation ApproachChao Chen, Hugh Zhu, Frédéric Stauffer, et al.
Pageof 3